PIGMENTED VILLONODULAR SYNOVITIS

Clinical trials for PIGMENTED VILLONODULAR SYNOVITIS explained in plain language.

Never miss a new study

Get alerted when new PIGMENTED VILLONODULAR SYNOVITIS trials appear

Sign up with your email to follow new studies for PIGMENTED VILLONODULAR SYNOVITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 3 Completed 1

Cancer drug repurposed to fight rare, recurring joint tumor

Disease control Completed

This study tested whether nilotinib, a drug used for leukemia, could help control a rare, non-cancerous joint tumor called pigmented villonodular synovitis (PVNS) when it comes back or spreads. Seventeen adults with recurrent or metastatic PVNS took nilotinib pills twice daily. T…

Matched conditions: PIGMENTED VILLONODULAR SYNOVITIS

Phase: PHASE2 • Sponsor: Andrew J. Wagner, MD, PhD • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PIGMENTED VILLONODULAR SYNOVITIS

Get alerted when new PIGMENTED VILLONODULAR SYNOVITIS trials appear

Cancer drug repurposed to fight rare, recurring joint tumor